Skip to main content
Download PDF

Ethanol responsive lnc171 promotes migration and invasion of HCC cells via mir-873-5p/ZEB1 axis

BMC Cancer volume 24, Article number: 550 (2024) Cite this article

Abstract

Backgrounds

Long nonconding RNAs (lncRNAs) have been found to be a vital regulatory factor in the development process of human cancer, and could regarded as diagnostic or prognostic biomarkers for human cancers. Here, we aim to confirm the expression and molecular mechanism of RP11-171K16.5 (lnc171) in hepatocellular carcinoma (HCC).

Methods

Screening of differentially expressed lncRNAs by RNA sequencing. Expression level of gene was studied by quantitative real-time PCR (qRT-PCR). The effects of lnc171, mir-873-5p, and ethanol on migration and invasion activity of cells were studied used transwell assay, and luciferase reporter assay was used to confirm the binding site.

Results

RNA sequencing showed that lnc171 was markedly up-regulated in HCC. siRNA-mediated knockdown of lnc171 repressed the migration and invasion ability of HCC cells. Bioinformatic analysis, dual luciferase reporter assay, and qRT-PCR indicated that lnc171 interacted with mir-873-5p in HCC cells, and Zin-finger E-box binding homeobox (ZEB1) was a downstream target gene of mir-873-5p. In addition, lnc171 could enhance migration and invasion ability of HCC cells by up-regulating ZEB1 via sponging mir-873-5p. More interestingly, ethanol stimulation could up-regulate the increase of lnc171, thereby regulating the expression of competing endogenous RNA (ceRNA) network factors which lnc171 participated in HCC cells.

Conclusions

Our date demonstrates that lnc171 was a responsive factor of ethanol, and plays a vital role in development of HCC via binding of mir-873-5p.

Peer Review reports

Backgroud

Hepatocellular carcinoma (HCC) is the fourth most common type of cancer and the second most common cause of cancer associated deaths [1]. There are nearly one million new cases of HCC and over ¾ million HCC related deaths worldwide every year [2, 3]. Unfortunately, although progress have been made in early diagnosis and specialized treatments in recent years, only limited HCC patients get help, and majority of HCC patients still have bad prognosis [4, 5]. Therefore, understanding the pathological conditions underlying carcinogenesis and development of HCC, seeking new diagnosis and therapeutic method, is of great significance for ameliorating the quality of life and reducing adverse prognosis in HCC patients.

Long noncoding RNAs (lncRNAs) are members of the non-coding transcriptome family with a length of over 200 nucleotides and play significant functional roles in multiple human cancer, including HCC [5,6,7]. Current research illustrated that lncRNA could conduct as competing endogenous RNA (ceRNA) and take part in regulating numerous cellular processes [8]. ceRNA network is a novel mechanism that reveals RNA (lncRNA-miRNA-mRNA) interactions [9] and it uncover that cytoplasm lncRNAs can regulate target genes by competing with mRNA for microRNA (miRNA) binding site [5, 6, 10]. Zhang et al. found that over-expression of NEAT1 combine with mir-362-3p, indirectly enhance the MIOX expression, lead to promote erastin and RSL3 induced ferroptosis in HCC cells [6].

Dysregulation of lncRNA expression were commonly seen in numerous cancer [11,12,13]. However, what factors may cause changes of lncRNA expression in human body? Several studies have shown that many pathogenic factors or disease inducements may lead to abnormal expression of lncRNA [14, 15]. For example, alcohol, one of the risk factors of HCC, that could induce alcoholic hepatitis which gradually develop into alcoholic cirrhosis and eventually leading to the occurrence of HCC [16]. And alcohol have been shown to be an epigenetic modulator that could stimulate cells to secreted variety of cytokine factors including lncRNA [17,18,19]. However, the function and mechanism of lncRNA in the process of alcohol-induce liver injury and HCC remains unknow.

In the present study, we found a new function of lncRNA, RP11-171K16.5 (lnc171), was aberrantly upregulated in human HCC. Furthermore, we confirmed that lnc171 could competitively sponge on mir-873-5p to affect its downstream gene-ZEB1 resulting to enhance HCC cells migration and invasion. More interestingly, we found that lnc171 was a responsive factor of ethanol and determined the regulatory mechanism involved in ethanol-induced lnc171 in HCC cells.

Materials and methods

Patients blood sample and RNA-Sequencing analysis

The blood samples of HCC patients and healthy controls (HC) were obtained for RNA sequencing were all from the First Affiliated Hospital of Guangxi Medical University. The methods of blood collection and RNA-sequencing refer to the previous published articles [20]. Briefly, RNA of Plasma exosomes from HCC patients and healthy controls were extracted for RNA-sequencing. The raw read sequences were filtered to remove adapter sequences and low-quality reads (more than 20% bases with quality less than 20, or reads with more than 10% undefined nucleotides) by using Skewer and the FastX-Toolkit software. Reads were mapped with human reference rRNA sequences (GenBank and GENCODE v26); reads that did not map with rRNA (clean reads) were subjected to subsequent analysis. Clean reads were aligned to human reference genome assembly (GRCh38) to define mRNA and lncRNA profiles by HISAT2 aligner with the default parameters. Clean reads were also annotated to GENCODE (v26) and the transcript expression level was quantified by the Expectation-Maximization (RSEM) package. Expression levels were calculated by reads per kilobase of transcript per million mapped reads. The sequencing results of HCC patients and healthy controls were compared. When the |fold change|≥2.0 and P < 0.05 of the transcript, it could be considered that the expression of the transcript was different between HCC patients and healthy controls.

Cell culture

Normal hepatocyte (HL7702) and HCC cells (Hep3B and Huh7) were obtained from Chinese Academy of Sciences (Shanghai, China). Dulbecco’s modified Eagle’s medium (Invitrogen, USA) was used to culture HL7702 and Huh7 cells, and Minimum Essential medium (Invitrogen, USA) was used to culture Hep3B. The composition of the cell culture medium was as follows: 98% culture medium, 10% fetal bovine serum (Thermo Fisher Scientific, USA), and 1% penicillin-streptomycin (Thermo Fisher Scientific, USA). All cells were placed in a 37℃ humidified incubator with 95% air and 5% CO2.

Establishment of ethanol treated cell model

HL7702 (2.5 × 105 per well), Huh7 (2.5 × 105 per well) and Hep3B (3.0 × 105 per well) cells were plated in 6-well plates with 2 ml complete medium for 12 h, then remove the culture medium and added 2 ml of 200 mM ethanol (24 µl anhydrous ethanol to 2 ml complete medium) into each well and cultured for 48 h to establish ethanol treated cell model. The control group was added with 2 ml complete medium.

Cell transfection

Three small interfering RNAs of lnc171, inhibitor and mimics of mir-873-5p were designed and construction by Sangong Biotech (Table S1) (Shanghai, China). siRNA, mir-873-5p inhibitor and mimics were transfected by Lipofectamine 3000 (Thermo Fisher Scientific, USA). Before transfection, cells were plated in 6-well plates (HL7702 and Huh7 cells: 2.5 × 105 per well; Hep3B cells: 3.0 × 105 per well) with 2 ml complete medium for 12 h. Three si171, mir-873-5p mimics, mir-873-5p inhibitor, and negative control (NC) were transfected, respectively, into the appropriate cell group, then added with 2 ml Opti-MEM medium without SBF per well following the manufacturer’s instruction.

Transwell assay

Transwell chambers (pore size 8 μm; Coning, USA) were used to conduct transwell assay with or without matrigel (BD Biosciences, USA). After transfection or ethanol treatment, cells (HL7702 and HepG2 cells: 5 × 104 per well; Hep3B cells: 7 × 104 per well) were cultured in the dishes with 200 ml serum-free medium. The bottom chamber was added with 600 µl of completed cultured medium. After incubation for 48 h, cells that migrated or invaded to the bottom of the filter membrane were fixed with methanol, stained with 0.5% crystal violet solution then photographed. Three fields were randomly selected and the relative cell number was calculated.

Quantitative real-time PCR analysis

The process of total RNAs extraction, RNA reverse transcription, and qRT-PCR was according to our previously study [20]. The 2−ΔΔCt method was used to calculate the relative folding changes of gene expression. U6 andβ-actin were used as an endogenous control. Primer sequences were listed in Table S2.

Western blot assay

The process of obtain the cellular protein, protein quantitation, protein electrophoresis, and protein bands detection were according to our previously study [20]. Briefly, RIPA Buffer (Beyotime Biotechnology, Shanghai, China) was used to lyse cells. The concentrations of protein were quantified using BCA kit (Beyotime Biotechnology, Shanghai, China). Then separated the protein by sodium dodecyl sulfate (SDS)-PAGE on 10% gels and transferred to poly-vinylidene difluoride (PVDF) membranes (the membranes were cut to appropriate size prior to hybridisation with antibodies during blotting) (Sigma-Alcdrih, St. Louis, MO, USA). After overnight incubation with first antibodies, then incubated for 2 h in the presence of secondary antibody and washed 3 times with TBST for 5 min. Quantity-one software (Bio-Rad Laboratories, USA) using the ECL-chemiluminescent kit. The signal of protein bands was quantified by ImageJ software for Windows (NIH, USA). The first antibody was ZEB1 (200 kDa, ab203829, dilution 1:500, Abcam, UK), GAPDH (37 kDa, 14C10, dilution 1:1000, Cell Signaling Technology, USA). The secondary antibody was HRP-conjugated Goat anti-rabbit IgG (abs20040ss, dilution 1:1000, absin, China).

Luciferase reporter assay

The binding sites between lnc171 and mir-873-5p, and between mir-873-5p and ZEB1 were predicted by online website. The DNA fragments of wild-type-lnc171 (lnc171-WT), mutant-lnc171 (lnc171-MUT), Wild-type-ZEB1, and mutant-ZEB1 were cloned into the pmiRGLO vector (Promega, USA). The HEK-293T cells was selected to perform luciferase reporter assay and were seeded on 96-well plate, then mir-873-5p NC or mir-873-5p mimics were transfected with wild- or mutant-type luciferase plasmids using Lipofectamine 3000 for 48 h. After transfection, the fluorescence intensity of firefly and Renilla was measure by Luciferase reporter kit (Yisheng Bio-Technology, China) and Multifunctional enzyme labeling instrument (Tecan, CH).

Bioinformatics analysis

The target gene of lnc171 or mir-873-5p were predicted by miRDB (https://mirdb.org/), TargetScan (https://www.targetscan.org/), and MicroT-CDS (https://dianalab.e-ce.uth.gr/html/dianauniverse/index.php?r=microT_CDS). miRDB could show the binding sites of target genes. UALCAN (https://ualcan.path.uab.edu/index.html) was used to obtain expression level data in HCC patients of ZEB1 that link TCGA database. ONCOLNC (http://www.oncolnc.org/) was used to obtain survival data of ZEB1 which link TCGA database.

Statistical analysis

All data were analyzed using SPSS20.0 software. Using GraphPad Prism 5.0 software to draw graphs. All data were represented as the mean ± S.D. The comparison of the data between two experimental groups was conducted by using Student’s t-test, and the comparison of multiple groups was conducted by using one-way ANOVA. p < 0.05 (*), p < 0.005 (**) and p < 0.0005 (***), were significant statistical.

Results

Lnc171 was highly expressed in HCC, and ethanol consumption enhance lnc171 expression

According to the fold change ≥ 2.0 and p < 0.05, we found a total of 17,778 DE-lncRNAs from the result of RNA-sequence (Fig. 1a, b), and lnc171 was highly up-regulated in plasma exosome of HCC patients (p < 0.05) (Fig. 1c). Then we used qRT-PCR to measure the level of lnc171, and found that lnc171 was higher expressed in three HCC cell lines than in HL7702 cells (p < 0.05) (Fig. 1d). Some studies have reported that ethanol could induce changes of lncRNA levels in cells [17,18,19], so we constructed a cell model of ethanol treatment to observe whether ethanol can cause changes of lnc171 levels in HCC cells. Before establishing the cell model, we treated cells with gradient concentration of ethanol and measured cellular activity at 24 h, 48 h, and 72 h after ethanol treatment. The results showed that cells still maintained good activity when treated with 200 µM ethanol for 48 h (p > 0.05) (Figure S1). Hence, we chose to treat cells with 200 µM ethanol for 48 h to construct the cell model. Then we found that after ethanol stimulation, the expression of lnc171 was higher than before stimulation in HCC cells (p < 0.05) (Fig. 1e).

Fig. 1
figure 1

lnc171 was over-expressed in HCC and ethanol stimulation enhance this phenomenon. (a) Volcano plot showing DE-lncRNAs between HCC-exos and healthy Ctrl-exos. (b) Hierarchical clustering of DE-lncRNA between HCC-exos and Ctrl-exos. (c) Expression level of lnc171 between HCC-exos and Ctrl-exos by RNA-Sequence. (d) Respective expression level of lnc171 in HCC cells was detected by qRT-PCR. (e) Respective expression level of lnc171 in hepatocyte and HCC cells after stimulated by ethanol was detected by qRT-PCR. *p < 0.05, **p < 0.005

Full size image

Ethanol promoted the migration and invasion of HCC cells by inducing an increase of lnc171

To explore the impact of lnc171 on the phenotype on cells, we knocked down lnc171 in HCC cells by using three siRNAs. As shown in Fig. 2a, lnc171 was reduced in cells when transfected with three siRNA, and the inhibition effect of si171-3 was the most obvious in HL7702 (p < 0.05) and Hep3B (p < 0.005), therefore, si171-3 was used for cell transfection in subsequent experiments and labeled as si171. After transfection with si171, we found that silencing lnc171 significantly reduced migration and invasion in HCC cells (p < 0.0005) (Fig. 2b, c).

Fig. 2
figure 2

Knockdown of lnc171 significantly inhibit cell migration and invasion phenotypes in hepatocyte and HCC cells. (a) Inhibitory rate of lnc171 after transfection with three siRNA respectively detected by qRT-PCR. Cell migration (b) and invasion (c) abilities were indicated by transwell assays (20X). *p < 0.05, **p < 0.005, ***p < 0.0005

Full size image

At previous experiments, we observed that lnc171 was significantly increased in HCC cells when stimulated by ethanol. In order to further demonstrate that lnc171 was an ethanol reactive factor and to understand the role of ethanol in cell migration and invasion, we silenced the expression of lnc171 after ethanol stimulation to test the changes in migration and invasion in HCC cells. The results showed that when irritated by ethanol, the expression of lnc171 was significantly up-regulated in Huh7 and Hep3B cells (p < 0.05) (Fig. 3a), and the migration and invasion of these two cells were significantly enhanced (p < 0.05) (Fig. 3b, c); however, when si171 was transfected after ethanol stimulation, the expression of lnc171 was clearly down-regulated (p < 0.05) (Fig. 3a), and the migration and invasion ability of Huh7 and Hep3B cells were also evidently decreased (P < 0.05) (Fig. 3b, c).

Fig. 3
figure 3

Ethanol stimulation up-regulate the expression of lnc171 and promote the migration and invasion of HCC cells. (a) Respective expression level of lnc171 in HCC cells after ethanol stimulated or ethanol stimulated combined with siRNA transfection was detected by qRT-PCR. Cell migration (b) and invasion (c) abilities were indicated by transwell assays (20X). *p < 0.05, **p < 0.005, ***p < 0.0005

Full size image

Lnc171 is a sponge of mir-873-5p

LncRNAs were known could sever as ceRNA to regulate miRNAs’ expression and biological activity [8]. Whether lnc171 could also act as ceRNA to participate in the migration and invasion process of HCC cells? In order to figure out the answer, we used online prediction software miRDB to predict the potential targets of lnc171. Then we found lnc171’s 3’-UTR ends include a binding site for mir-873-5p (Fig. 4a). And the result of dual-luciferase reporter assay also indicated that mir-873-5p mimic could remarkably suppressed the activity of luciferase of lnc171-WT 3’-UTR in 293T cells, however, no luciferase activity was observed in mir-873-5p mimic on mutant 3’UTR (p < 0.005) (Fig. 4b, c). In addition, transcriptome sequencing and qRT-PCR analysis also proved that the expression of mir-873-5p was opposite to lnc171 in Huh7 and Hep3B cells (Fig. 4d, e). Silence of lnc171 would inhibit the levels of lnc171 but up-regulated mir-873-5p levels in Huh7 and Hep3B cells (Fig. 4f). All these results indicating that mir-873-5p might serve as a target of lnc171.

Fig. 4
figure 4

Targeting relationship between lnc171 and mir-873-5p. (a) mir-873-5p putative binding site on lnc171 by miRDB. (b) Construction schematic diagram of lnc171-wild-type (lnc171-WT) and lnc171-mutant (lnc171-MUT) luciferase reporter vector. (c) Relative luciferase activity was detected in 293T cells cotransfected with lnc171-WT or lnc171-MUT vectors and mir-873-5p mimic or miR-negative control (miR-NC). (d) Expression level of mir-873-5p between HCC-exos and Ctrl-exos by RNA-Sequence. (e) Expression level of mir-873-5p in hepatocyte and HCC cells was detected by qRT-PCR. (f) Expression level of lnc171 and mir-873-5p in HCC cells after transfection with siRNA was detected by qRT-PCR. *p < 0.05, **p < 0.005, ***p < 0.0005

Full size image

Mir-873-5p inhibits migration and invasion of HCC cells via targeting ZEB1

We transfected mir-873-5p mimics into HL7702s, Huh7 and Hep3B cells to examine the influence of mir-873-5p in the migration and invasion in HCC cells. The results showed that over-expression of mir-873-5p suppressed the abilities of migration and invasion in HL7702, Huh7 and Hep3B cells compared with miR-NC group (p < 0.005) (Fig. 5a, b).

Fig. 5
figure 5

mir-873-5p inhibited cell migration and invasion by ZEB1. Cell migration (a) and invasion (b) abilities were indicated after transfected with mir-873-5p mimic or miR-NC by transwell assays (20X). (c) Venn diagram of target genes of mir-873-5p predicted by three target gene prediction sites, a total of 74 overlapping genes were screened. (d) KEGG pathway enrichment of 74 target gene of mir-873-5p. (e) Construction schematic diagram of ZEB1-WT and ZEB1-MUT luciferase reporter vector. (f) Relative luciferase activity was detected in 293T cells cotransfected with ZEB1-WT or ZEB1-MUT vectors and mir-873-5p mimic or miR-NC. *p < 0.05, **p < 0.005, ***p < 0.0005

Full size image

miRNA drive its function by regulating the expression of downstream genes. To identify the main target genes of mir-873-5p, the TargetScan, microT-CDS and miRDB were used. The number of target genes predicted by each database were 379, 1199 and 640, respectively. Then using Venny2.1 to intersect the results of three databases, and 74 intersecting target genes were obtained (Fig. 5c). KEGG pathway enrichment was performed on 74 target genes using DAVID, and four genes, BMPR2, HMOX1, HNRNPK and ZEB1, were enriched on the “microRNAs in cancer” signal pathway (Fig. 5d). Among these four gene, Zinc finger E-box binding homeobox 1 (ZEB1) is a key factor associated with tumor migration and invasion [21]. We used TagetScan Human 7.2 to analysis and find a binding site on 3’-UTR ends of ZEB1 for mir-873-5p (Fig. 5e), and a dual-luciferase reporter gene assay showed that mir-873-5p mimic significantly inhibited the luciferase activity of ZEB1 WT3’UTR in 293T cells, whereas mir-873-5p mimic had no significant effect on the luciferase activity of MUT3’UTR (p < 0.005) (Fig. 5f). This founding suggests us that mir-873-5p may regulate cell migration and invasion by ZEB1.

Lnc171 promotes migration and invasion of HCC cells by mir-873-5p/ZEB1 axis

As we had confirmed that mir-873-5p was targeted by lnc171, next we want to investigate whether lnc171 could affect the expression of ZEB1 which downstream of mir-873-5p. The results showed that compare with control, the expression level of mir-873-5p was low, while the mRNA and protein level of ZEB1 increased in Huh7 and Hep3B cells before lnc171 was silenced. In contrast, after lnc171 silencing, mir-873-5p was increased, while ZEB1 was decreased in both mRNA and protein level (p < 0.05) (Fig. 6a). Therefore, we have demonstrated that lnc171 could up-regulate the level of ZEB1 through inhibit the expression of mir-873-5p. However, does lnc171 regulate the migration and invasion ability of HCC cells through mir-873-5p/ZEB1axis? The results indicated that when lnc171 was inhibited, the migration and invasion ability was damaged in HCC cells; when mir-873-5p was inhibited, the migration and invasion of HCC cells was increased; however, when lnc171 and mir-873-5p were simultaneously inhibited, the migration and invasion ability of HCC cells was remained lower compared to the control (p < 0.05) (Fig. 6b, c). In addition, the results of western blot showed that ZEB1 mRNA levels decreased after lnc171 silencing, while increased after mir-873-5p inhibition. When both lnc171 and mir-873-5p were inhibited, ZEB1 protein levels still decreased compared to the control (Fig. 6d, e). These results suggesting that lnc171 could up-regulate the expression of ZEB1 by inhibiting the function of mir-873-5p, thereby promoting the migration and invasion of HCC cells.

Fig. 6
figure 6

lnc171 enhance cell migration and invasion by targeted mir-873-5p/ZEB1 axis. (a) Respective expression level of lnc171/mir-873-5p/ZEB1 in HCC cells after transfected with siRNA was detected by qRT-PCR. Cell migration (b) and invasion (c) abilities were indicated after transfected with siRNA or mir-873-5p inhibitor or siNC by transwell assays (20X). (d) Western blot images show protein expression change of ZEB1 after transfected with siRNA or mir-873-5p inhibitor or siNC. *p < 0.05, **p < 0.005, ***p < 0.0005

Full size image

Ethanol up-regulated lnc171 and enhance HCC cells migration and invasion by mir-873-5p/ZEB1 axis

Lnc171 proved to be a responsive factor of ethanol in our experiments. We silenced the expression of lnc171 after ethanol stimulation to detect the expression level of mir-873-5p and ZEB1 in HCC cells and found that ethanol irritation could increase the expression level of lnc171 and ZEB1 but decrease the level of mir-873-5p; nevertheless, when si171 was transfected after ethanol stimulation, the expression of lnc171 and ZEB1 was clearly down-regulated but mir-873-5p was up-regulated (p < 0.05) (Fig. 7a). In summary, ethanol stimulation can up-regulate the expression level of lnc171, thereby inhibiting the expression level of mir-873-5p and up-regulating the mRNA level of ZEB1. These results suggesting that ethanol can participate in the mir-873-5p/ZEB1 axis by up-regulating the level of lnc171 and promote the migration and invasion of HCC cells (Fig. 7d). ZEB1 is the final target protein of the ceRNA regulatory network (lnc171—mir-873-5p—ZEB1) in which lnc171 involved in, so we used an online database to further explore its value as a biomarker of HCC. The results indicated that the expression of ZEB1 in HCC tissues was significantly higher than that in normal tissues (p < 0.0005) (Fig. 7b), and HCC patients whose highly expression of ZEB1 had a poor prognosis (p < 0.05) (Fig. 7c). This illustrating that ZEB1 can be used as a prognostic marker for HCC.

Fig. 7
figure 7

Ethanol stimulation up-regulated the expression of lnc171 and promoted the proliferation of HCC cells through mir-873-5p/ZEB1 axis. (a) Respective expression level of lnc171/mir-873-5p/ZEB1 in HCC cells after ethanol stimulated or ethanol stimulated combined with siRNA transfection was detected by qRT-PCR. *p < 0.05 vs. NC, #p < 0.05 vs. EtOH, &p < 0.05 vs. EtOH + si171. (b) Expression of ZEB1 between normal and primary tumors in HCC patients in UALCAN database. (c) Overall survival (OS) curves for ZEB1 in low- and high-risk groups in the HCC patients using the Kaplan-Meier method in ONCOLNC database. (d) Working model of lnc171/mir-873-5p/ZEB1 axis stimulating by ethanol in HCC. *p < 0.05, **p < 0.005, ***p < 0.0005

Full size image

Discussion

LncRNAs can affect various biological processes through regulate the expression or activity of their downstream target genes, and are considered as one of the key regulatory factors for human cancer progression and drug resistance [5, 6]. There are increasing evidence suggest that lncRNAs present a vital role on the process of HCC occurrence and development and they are considered as a potential and novel biomarkers for the diagnosis and prognosis of HCC [22, 23]. Our present study screens out a novel lncRNA, lnc171, that increase remarkably in plasma exomes of HCC patients by RNA-sequencing and qRT-PCR. This lncRNA could badly impact HCC cells migration and invasion when it is knocking down, and this phenomenon has attracted our interest to study the mechanism of lnc171. LncRNA can combine with miRNAs, reducing the inhibitory regulation of miRNA on their target mRNAs’ translation [24]. Therefore, we used online software to predict the target miRNA—mir-873-5p of lnc171 and confirm their bonding.

mir-873-5p is one of the main members of mir-873 family that has been extensively studied. There are many genes targeted and regulated by mir-873-5p, these target genes have transcription regulation, catalytic activity, binding, and other molecular functions, which are closely related to the biological processes of cancer cells such as proliferation [25], apoptosis [26], migration [21], invasion [27]. mir-873-5p inhibit the invasion of papillary thyroid cancer cells by interfering with the expression of CXCL16 [28]. In addition, mir-873-5p could regulate triple-negative breast cancer cells’ proliferation and metastasis by inhibiting the MYC proto-oncogene, bHLH transcription factor [29]. The above research indicates that mir-873-5p was a tumor suppressor factor and has significant implications for the occurrence and development of cancer. Our study also demonstrated that mir-873-5p could significantly inhibited the migration and invasion of HCC cells.

In order to delve into the regulatory ceRNAs network that involved in lnc171 in HCC, we predicted the target genes that may be regulated downstream of mir-873-5p through prediction software, then found that ZEB1 may be regulated by mir873-5p. The regulatory relationship of between mir-873-5p and ZEB1 has also been reported in other studies [30, 31]. ZEB1 is a vital transcription factor that involved the procession in regulating epithelial-to-mesenchymal transition. And it has also been reported that ZEB1 was abnormally expressed in a variety of human cancers, which could promote cells’ migration, invasion, and metastasis [21, 27]. The study of Chen H shown that ZEB1 up-regulates the expression of centrosome protein 55 and affects the migration, invasion, and EMT of renal cell cancer cells [32]. Jesús MB confirmed that the role of ZEB1 silencing in reducing the migration and invasion ability of thyroid cancer cells [33]. In our study, it was found that lnc171 modulates increased both the mRNA or protein expression of ZEB1 by inhibiting mir-873-5p, thereby promoting the migration and invasion capacity of HCC cells. Therefore, we confirmed the lnc171—mir-873-5p—ZEB1 axis was an important pathway for regulating migration and invasion of HCC cells.

Alcohol abuse is one of the common risk factors for liver cancer [34]. Ethanol can induce liver damage and hepatic steatosis these lesions can cause alcoholic liver disease to progress to cirrhosis and eventually to HCC [35]. Ethanol has been proved to be a teratogenic agent and epigenetic regulator that regulates cell biological traits and functions by regulating the expression levels of multiple factors, leading to aggravating liver damage and accelerating the process of liver lesions [17,18,19]. In our study, we found that the stimulation of ethanol could increase the expression of lnc171 in HCC cells, and the migration and invasion ability of HCC cells was enhanced. In addition, ethanol stimulation reduced the expression of mir-873-5p and increased the expression of the ZEB1 protein which both downstream and regulated by lnc171. Therefore, we believe that ethanol can promote the migration and invasion of HCC cells through the lnc171—mir-873-5p—ZEB1 axis, making HCC malignant, which may be one of the mechanisms by which ethanol causes liver cancer. Inhibition of any factor of the lnc171—mir-873-5p—ZEB1 axis, especially the expression of lnc171, can inhibit the invasion and migration of HCC cells. Therefore, inhibitors targeting lnc171 may be one of the future treatment strategies of HCC. Promoting the expression of lnc171, such as alcohol intake, can promote the malignant progression HCC cells through the lnc171—mir-873-5p—ZEB1 axis. Therefore, reducing alcohol intake may be an important early warning measure for high-risk groups of HCC. Finally, we discussed the possibility that ZEB1 could be used as a biomarker for HCC and founding that ZEB1 is able to serve as a potential biomarker of HCC and helps to understanding the prognosis of HCC patients.

Conclusions

In this study, we found that lnc171, a novel lncRNA, was significantly upregulated in HCC, which can competitively bind mir-873-5p and thus leads to less mir-873-5p-mediated ZEB1 inhibition, thereby enhancing the sensitivity of migration and invasion of HCC cells. We identified a ceRNA regulatory network, the lnc171—mir-873-5p—ZEB1 axis, in HCC. We also found that ethanol stimulation could up-regulated the increase of lnc171 in HCC cells, thereby enhance the migration and invasion of HCC cells through the ceRNA network in which lnc171 participated. Our study reveals that lnc171 plays an important role in HCC progression and highlights the potential of lnc171 as a therapeutic target for HCC.

Data availability

The datasets generated and/or analyzed during the current study are available at https://pan.baidu.com/s/1HAhfHlMuaeJnWToecUhYAA. The code is sydw.

Abbreviations

HCC:

Hepatocellular carcinoma

HC:

Healthy control

lncRNA:

Long noncoding RNA

ceRNA:

Competing endogenous RNA

miRN A:

microRNA

FBS:

Fetal bovine serum

PS:

Penicillin streptomycin

NC:

Negative control

qRT-PCR:

Quantitatice real time polymerase chain reaction

ZEB1:

Zin-finger E-box binding homeobox

References

  1. Reina S, Tatsuo K, Osamu Y, et al. Exosomes and Hepatocellular Carcinoma: from bench to Bedside. Int J Mol Sci. 2019;20(6):1406.

    Article  Google Scholar 

  2. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.

    Article  PubMed  Google Scholar 

  3. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29.

  4. Liu ZY, Liu X, Liang JX, et al. Immunotherapy for Hepatocellular Carcinoma: current status and future prospects. Front Immunol. 2021;12:765101.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Xu FF, Zha GQ, Wu YP, et al. Overexpressing lncRNA SNHG16 inhibited HCC proliferation and chemoresistance by functionally sponging hsa-miR-93. Onco Targets Ther. 2018;11:8855–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Zhang Y, Luo MY, Cui XH, et al. Long noncoding RNA NEAT1 promotes ferroptosis by modulating the miR-362-3p/MIOX axis as a ceRNA. Cell Death Differ. 2022;29(9):1850–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Deng L, Yang SB, Xu FF, Zhang JH. Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let-7 sponge. J Exp Clin Cancer Res. 2015;34:18.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Mary CB, Amanda CD, Antonis K. LNCcation: lncRNA localization and function. J Cell Biol. 2021;220(2):e202009045.

    Article  Google Scholar 

  9. Shi Y, Liu JB, Deng J, et al. The role of ceRNA-mediated diagnosis and therapy in hepatocellular carcinoma. Hereditas. 2021;158(1):44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Chen TX, Liu RK, Niu YS, et al. HIF-1α-activated long non-coding RNA KDM4A-AS1 promotes hepatocellular carcinoma progression via the miR-411-5p/KPNA2/AKT pathway. Cell Death Dis. 2021;12(12):1152.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Shan Lu L, Dong X, Jing, et al. Abnormal lncRNA CCAT1/microRNA-155/SIRT1 axis promoted inflammatory response and apoptosis of tubular epithelial cells in LPS caused acute kidney injury. Mitochondrion. 2020;53:76–90.

    Article  PubMed  Google Scholar 

  12. Liao Z, Nie H, Wang Y, et al. The Emerging Landscape of Long non-coding RNAs in Colorectal Cancer Metastasis. Front Oncol. 2021;11:641343.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Xue Wang C, Gao F, Feng, et al. Construction and analysis of competing endogenous RNA networks for breast Cancer based on TCGA dataset. Biomed Res Int. 2020;2020:4078596.

    PubMed  PubMed Central  Google Scholar 

  14. Gao YN, Wang ZW, Yang X et al. Aflatoxin M1 and ochratoxin A induce a competitive endogenous RNA regulatory network of intestinal immunosuppression by whole-transcriptome analysis. Sci Total Environ. 2022. 14;158777.

  15. Chao H, Ma H, Sun J, et al. Whole-transcriptome analysis of non-coding RNA alteration in porcine alveolar macrophage exposed to aflatoxin B1. Toxins (Basel). 2022;14(6):373.

    Article  CAS  PubMed  Google Scholar 

  16. Yang JD, Hainaut P, Gregory J, Gores, et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589–604.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Choi MR, Cho S, Kim D-J, et al. Effects of ethanol on expression of coding and noncoding RNAs in murine neuroblastoma Neuro2a cells. Int J Mol Sci. 2022;23(13):7294.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Wu Y, Qi YB, Bai YQ, et al. LncRNA 1700020I14Rik promotes AKR1B10 expression and activates Erk pathway to induce hepatocyte damage in alcoholic hepatitis. Cell Death Discov. 2022;8(1):374.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Yan YF, Ren L, Liu Y, et al. Long non-coding RNA CRNDE as potential biomarkers facilitate inflammation and apoptosis in alcoholic liver disease. Aging. 2021;13(19):23233–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Huang XJ, Sun LY, Wen S, et al. RNA sequencing of plasma exosomes revealed novel functional long noncoding RNAs in hepatocellular carcinoma. Cancer Sci. 2020;111(9):3338–49.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Li YH, Zhong M, Zang HL, Tian XF. The E3 Ligase for Metastasis Associated 1 protein, TRIM25, is targeted by microRNA-873 in Hepatocellular Carcinoma. Exp Cell Res. 2018;368(1):37–41.

    Article  CAS  PubMed  Google Scholar 

  22. Qin G, Tu X, Li H, Cao P, Chen X, Song J, et al. Long noncoding RNA p53-stabilizing and activating RNA promotes p53 signaling by inhibiting heterogeneous nuclear ribonucleoprotein K deSUMOylation and suppresses hepatocellular carcinoma. Hepatology. 2020;71:112–29.

    Article  CAS  PubMed  Google Scholar 

  23. Hu JJ, Zhou C, Luo X, Luo SZ, Li ZH, Xu ZX, et al. Linc-SCRG1 accelerates progression of hepatocellular carcinoma as a ceRNA of miR26a to derepress SKP2. J Exp Clin Cancer Res. 2021;40:26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Salmena L, Poliseno L, Tay Y, et al. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 2011;146:353–58.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Zhang Y, Zhang C, Zhao Q, et al. The miR-873/NDFIP1 Axis promotes Hepatocellular Carcinoma Growth and Metastasis through the AKT/mTOR-Mediated Warburg Effect. Am J Cancer Res. 2019;9(5):927–44.

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Wang L, Jiang F, Ma F, et al. Mir-873-5p suppresses cell proliferation and epithelial-mesenchymal transition via directly targeting Jumonji Domain-Containing protein 8 through the NF-kappaB pathway in Colorectal Cancer. J Cell Commun Signal. 2019;13(4):549–60.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Chen X, Zhang Y, Shi Y, et al. MiR-873 acts as a Novel Sensitizer of Glioma cells to cisplatin by targeting Bcl-2. Int J Oncol. 2015;47(4):1603–11.

    Article  CAS  PubMed  Google Scholar 

  28. Wang Z, Liu W, Wang C, et al. Mir-873-5p inhibits cell migration and invasion of papillary thyroid cancer via regulation of CXCL16. Onco Targets Ther. 2020;13:1037–46.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Tang L, Chen Y, Tang X, et al. Long noncoding RNA DCST1-AS1 promotes cell proliferation and metastasis in triple-negative breast cancer by forming a positive regulatory loop with mir-873-5p and MYC. J Cancer. 2020;11:311–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Li G, Xu Y, Wang S, et al. Mir-873-5p inhibits cell migration, invasion and epithelial-mesenchymal transition in colorectal cancer via targeting ZEB1. Pathol Res Pract. 2019;215(1):34–9.

    Article  CAS  PubMed  Google Scholar 

  31. Xiufeng H, Wang YMJ et al. LncRNA TDRG1 promotes the metastasis of NSCLC cell through regulating mir-873-5p/ZEB1 axis. J Cell Biochem. 2019; Online ahead of print.

  32. Chen H, Zhu D, Zheng Z, et al. CEP55 promotes epithelial mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway. Clin Transl Oncol. 2019;21(7):939–49.

    Article  CAS  PubMed  Google Scholar 

  33. Morillo-bnernal J, Fernandez LP, Santisteban P. FOXE1 regulates migration and invasion in thyroid cancer cells and targets ZEB1. Endocr Relat Cancer. 2020;27(3):137–51.

    Article  Google Scholar 

  34. Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.

    Article  PubMed  Google Scholar 

  35. Bichitra P, Monika L, Jesper BA. Lipid alterations in chronic liver disease and liver cancer. JHEP Rep. 2022;4(6):100479.

    Article  Google Scholar 

Download references

Acknowledgements

Thanks very much for the support of the above funds for our research.

Funding

This work was supported by Guangxi Natural Science Foundation project (2021GXNSFBA220014); Program of Key Laboratory of High-Incidence-Tumor Prevention and Treatment (Guangxi Medical University), Ministry of Education, China (GKE-ZZ202212, GKE-ZZ202108, GKE-ZZ202002 and GKE2019-03); Science Foundation of China-ASEAN Laboratory Animal Science and technology Innovation Center, Guangxi Medical University (KCZX2022001, KCZX2022009), Guangxi Medical University Youth Science Foundation project (GXMUYSF202109).

Author information

Author notes

  1. Shiping Huang, Zhouxiang Liao and Xiao He contributed equally to this work.

Authors and Affiliations

  1. School of Public Health, Guangxi Medical University, Nanning, 530021, China

    Shiping Huang, Zhouxiang Liao, Zhenyu Song, Sha Wen, Hui Li, Wanling Mo, Xiaojing Cheng & Min He

  2. School of Public Health, Guilin Medical School, Guilin, 541199, China

    Xiao He

  3. Laboratory Animal Center of Guangxi Medical University, Nanning, 530021, China

    Xi Fang, Sha Wen, Lichao Yang, Qi Zhang, Min He & Xuejing Huang

  4. Life Sciences Institute of Guangxi Medical University, Nanning, 530021, China

    Xiaojing Cheng

  5. Key Laboratory of High-Incidence-Tumor Prevention & Treatment, Guangxi Medical University, Ministry of Education, Nanning, 530021, China

    Min He

Authors
  1. Shiping Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhouxiang Liao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiao He
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhenyu Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xi Fang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sha Wen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Lichao Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hui Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Qi Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Wanling Mo
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Xiaojing Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Min He
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Xuejing Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

SH and ZL performed the experiments, analyzed data, and wrote the original draft. HL, WM, SW, QZ, XF and ZS investigated and validated statistics data. LY, XH, and XC wrote and revised the manuscript. XH, MH and XH designed the study, supervised all experiments, and supported the study. All authors approve the submitted version of the manuscript.

Corresponding authors

Correspondence to Min He or Xuejing Huang.

Ethics declarations

Ethics approval and consent to participate

This study was approved by ethics committee of Guangxi Medical University (protocol no. 20170302-1), and the written informed consent was obtained from all participants of this study. All methods were undertaken in accordance with the guidelines.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huang, S., Liao, Z., He, X. et al. Ethanol responsive lnc171 promotes migration and invasion of HCC cells via mir-873-5p/ZEB1 axis. BMC Cancer 24, 550 (2024). https://doi.org/10.1186/s12885-024-12309-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12885-024-12309-3

Keywords

BMC Cancer

ISSN: 1471-2407

Contact us